The ligand of CD40, known as CD154 or CD40L, is a type II transmembrane protein, with a variable molecular weight between 32 and 39 kDa because of post-translation modifications. CD40L is a member of the TNF superfamily and is characterized by a sandwich extracellular structure that is composed of a β-sheet, α-helix loop, and a β-sheet. CD40L is expressed primarily by activated T cells, as well as activated B cells and platelets; and under inflammatory conditions is also induced on monocytic cells, natural killer cells, mast cells, and basophils.
This report elaborates the market size, market characteristics, and market growth of the CD40 Ligand industry, and breaks down according to the type, application, and consumption area of CD40 Ligand. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for CD40 Ligand in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global CD40 Ligand market covered in Chapter 13:
ImmuNext, Inc.
Bristol-Myers Squibb Company
MedImmune, LLC
eTheRNA Immunotherapies NV
XL-protein GmbH
Targovax AS
Biogen, Inc.
Juno Therapeutics Inc.

In Chapter 6, on the basis of types, the CD40 Ligand market from 2015 to 2025 is primarily split into:
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others

In Chapter 7, on the basis of applications, the CD40 Ligand market from 2015 to 2025 covers:
Autoimmune indications
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025